BIO-RAD LABORATORIES, INC. Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
BIO-RAD LABORATORIES, INC. (BIO) reported Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents of $11.30 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Change in Cash
us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-04
- BIO-RAD LABORATORIES, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2026-03-31 was $5.90M.
- BIO-RAD LABORATORIES, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2025-03-31 was -$1.80M, a 166.67% decline year-over-year.
- BIO-RAD LABORATORIES, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2024-03-31 was $2.70M.
- BIO-RAD LABORATORIES, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2023-03-31 was -$2.00M, a 129.02% decline year-over-year.
| Period end | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3 month as first filed | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6 month as first filed | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11.30M 10-Q · filed 2026-08-04 | |||||
| 2026-03-31 | $5.90M 10-Q · filed 2026-04-30 | |||||
| 2025-09-30 | -$16.90M 10-Q · filed 2025-10-29 | |||||
| 2025-06-30 | -$18.00M 10-Q · filed 2026-08-04 | |||||
| 2025-03-31 | -$1.80M 10-Q · filed 2026-04-30 | |||||
| 2024-09-30 | -$900.00K 10-Q · filed 2025-10-29 | -$1.02M 10-Q · filed 2024-10-31 | ||||
| 2024-06-30 | $6.50M 10-Q · filed 2025-07-31 | $6.49M 10-Q · filed 2024-08-02 | ||||
| 2024-03-31 | $2.70M 10-Q · filed 2025-05-01 | $2.66M 10-Q · filed 2024-05-08 | ||||
| 2023-09-30 | $6.89M 10-Q · filed 2024-10-31 | |||||
| 2023-06-30 | $670.00K 10-Q · filed 2024-08-02 | |||||
| 2023-03-31 | -$2.00M 10-Q · filed 2024-05-08 | |||||
| 2022-09-30 | $21.17M 10-Q · filed 2023-10-27 | |||||
| 2022-06-30 | $13.67M 10-Q · filed 2023-08-04 | |||||
| 2022-03-31 | $6.88M 10-Q · filed 2023-05-05 | |||||
| 2021-09-30 | -$11.17M 10-Q · filed 2022-10-28 | |||||
| 2021-06-30 | -$5.10M 10-Q · filed 2022-07-29 | |||||
| 2021-03-31 | -$7.35M 10-Q · filed 2022-04-29 |